Will we have chips in our heads? Will our DNA be connected to our search history? Let's learn together here for information--not investment crystal ballsmanship
$GOVX milestones met, including plans for a Phase 2 trial of Gedeptin for first recurrent head and neck cancer in combination with an immune checkpoint inhibitor. Full report here. https://t.co/BqnSLwYo67
Join BioUtah & the UK government for a FREE webinar on navigating the UK health market & accessing innovation support. #utah#UK#MoU#lifesciences#UKMoUhealth
https://t.co/LQYx9lqGOv
By interrupting cancer signaling before it spreads to redundant pathways, PCLX-001 offers a potent alternative to classic chemotherapies and immunotherapies to kill cancer cells
https://t.co/sALZwQeup1
#BiotechShowcase#BiotechShowcase2023#cancer#PCLX-001 #leukemia#lymphoma